Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
Ashima Gulati(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Sonika Sharma, Stanley C. Jordan(Cedars-Sinai Medical Center), Pankaj Hari(Indian Council of Medical Research), Asha Moudgil(Children's National), Aditi Sinha, Amit Kumar Dinda(All India Institute of Medical Sciences)
Cited by 203
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
|American Journal of Kidney Diseases|2003|140